FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Active, responses due . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM EST
- Posted
- November 17, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- PSC
- AJ11: GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- Last updated
- Nov 17, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- FDABAA-27-00123
- Notice ID
- f66b0def19bc4d39b935220b1722cdd3
Description
Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm.
Updated the Special Notice Archive date from 15 days after response date to 09/30/27.
Amendment 002 - 11/16/26:
Summary of changes BAA Notice (FDABAA-27-00123) - Amendment 002:
- Page 2 – Added updated information on BAA Day.
- BAA Day: FY27 FDA BAA Day will provide an opportunity to learn more about the application process and the FDA’s priorities for regulatory science research. Fiscal Year (FY) 2027 FDA Broad Agency Announcement Day - 12/08/2026 | FDA
- Page 7 – Added updated information on BAA Day.
- BAA Day for FY2027 will be hosted on December 8, 2026 from 1:00 PM - 4:00 PM Eastern Standard Time, as a virtual only event and will provide an opportunity to learn more about the application process and FDA’s priorities for regulatory research (Fiscal Year (FY) 2027 FDA Broad Agency Announcement Day - 12/08/2026 | FDA).
- Page 14 – Added new research interest to Section - 2. Enhancing Nonclinical Development
- 16. Compare multiple human tooth enamel evaluation techniques (including but not limited to surface and cross-sectional microhardness) to explore critical parameters and refine demineralization-remineralization NAMs for the testing of over-the-counter anticaries dentifrice drug products.
- Page 52 – Updated Section - 22 - Tobacco and Nicotine with Super Intelligence (SI)
- (SI)[18]
- [18] Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI)
- Page 53-56 - Section - 22 - Tobacco and Nicotine
- Updated numerical bullet points. The content did not change.
- Added page numbers to the footer of the BAA Notice.
Notice:
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (6)
- Download
BAA Notice Conformed through Amendment 002 CLEAN 11.16.26.pdf
804 KBAdded in Special Notice version 4Posted - Download
FY27 BAA - Amendment 002 - Summary of Changes.pdf
207 KBAdded in Special Notice version 4Posted - Download
BAA Notice Final 10.29.26.docx
316 KBAdded in Special Notice version 1Posted - Download
Attachment_6_SOW_Template.docx
16 KBAdded in Special Notice version 1Posted - Download
Cost_Appendix_7_Proposal_Template.xlsx
196 KBAdded in Special Notice version 1Posted - Download
Cost_Appendix_8_PreawardSurvey_Accounting_System.pdf
1.4 MBAdded in Special Notice version 1Posted
Lifecycle
- 1Version 1Special Notice
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- 2Version 2Special Notice
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- 3Version 3Special Notice
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- 4Version 4Special NoticeCurrent
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDABAA-27-00123
Archive Date
Sep 30, 2027
Office Address
Rockville, MD, 20852